Namandje Bumpus stock trades
Director of Recursion Pharmaceuticals
2 open-market trades reported in the last 12 months: 2 sales for $28K. Every sale was under a trading plan set up in advance. The newest was filed Jun 22.
Where Namandje Bumpus files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 2 |
Namandje Bumpus's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$13K | Jun 18SEC filing | |
| SellPlan$16K | Jun 3SEC filing |
1 other filing on record (stock award). Pro members see every trade, the shares Namandje Bumpus held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.